What is Ironwood Pharmaceuticals's non-cash lease expense?

Ironwood Pharmaceuticals (IRWD) reported non-cash lease expense of $444K in Q1 2026.

How has Ironwood Pharmaceuticals's non-cash lease expense changed year-over-year?

Ironwood Pharmaceuticals's non-cash lease expense increased by 8.6% year-over-year, from $409K to $444K.

What does non-cash lease expense mean?

Non-cash portion of operating lease cost — the difference between straight-line lease expense and actual cash rent payments.

Ironwood Pharmaceuticals IRWD Non-Cash Lease Expense

Non-Cash Lease Expense at other companies

ArdelyxARDX

$362K-60.8%

Eton Pharmaceuticals, Inc.ETON

$9K-47.1%

ANI PharmaceuticalsANIP

$453K+0.2%

Ionis PharmaceuticalsIONS

$3.49M+34.7%

TG TherapeuticsTGTX

$573K+26.5%

Neurocrine BiosciencesNBIX

——

Other financials

Income statement

See full

Revenue$106.5M+159%

Operating income$72.6M+349%

Net income$40.8M+209%

EPS (diluted)$0.24+204%

Balance sheet

See full

Cash & equivalents$220.5M+103%

Total debt$212.4M+1,323%

Total equity-$217.1M+35.0%

Total assets$434.6M+32.8%

Cash flow

See full

Operating cash flow$5.1M-74.3%

CapEx-—

Free cash flow$74.6M+390%

Valuation

See full

Market cap$632.12M+457%

Enterprise value$624M+3,024%

P/E6.2×—

P/S1.8×+1.4×

Profitability

See full

Gross margin99.2%—

Operating margin55.4%+38.7pp

Net margin28.3%+22.3pp

FCF margin24.7%-11.1pp

Returns & leverage

See full

Return on equity29.7%-138pp

Debt / equity0×-0.5×

Current ratio1.4×-1.9×

Where this comes from

Reported directly by Ironwood Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.

The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ironwood Pharmaceuticals's non-cash lease expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ironwood Pharmaceuticals's non-cash lease expense?: Ironwood Pharmaceuticals (IRWD) reported non-cash lease expense of $444K in Q1 2026.
How has Ironwood Pharmaceuticals's non-cash lease expense changed year-over-year?: Ironwood Pharmaceuticals's non-cash lease expense increased by 8.6% year-over-year, from $409K to $444K.
What does non-cash lease expense mean?: Non-cash portion of operating lease cost — the difference between straight-line lease expense and actual cash rent payments.